AZN Financial Statements & Analysis
Complete financial statements for AZN including income statement, balance sheet, and cash flow statement. Analyze AZN's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
57
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
18.0% ↑
Net Income
18.1% ↑
Gross Margin
-1.6% ↓
Operating Margin
3.4% ↑
Balance Sheet
Current Ratio
13.0% ↑
Debt to Equity
1.0% ↓
Asset Turnover
14.7% ↑
Cash Flow
Operating Cash Flow
14.7% ↑
Net Cash Flow
39.9% ↑
Free Cash Flow
10.8% ↑
Cash Flow to Debt
9.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 45.81B | 54.07B | 18.0% | |
| Gross Profit | 37.77B | 43.87B | 16.1% | |
| Operating Income | 8.19B | 10.00B | 22.1% | |
| Net Income | 5.96B | 7.04B | 18.1% | |
| EPS | 1.91 | 2.27 | 18.8% | |
| EBITDA | 13.91B | 15.44B | 11.0% | |
| Gross Margin | 82.45% | 81.12% | 1.6% | |
| Operating Margin | 17.88% | 18.50% | 3.4% | |
| Net Income Margin | 13.00% | 13.01% | 0.1% | |
| R&D Expenses | 10.94B | 13.58B | 24.2% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 54.07B | 45.81B | 44.35B | 37.42B | 26.62B |
| Gross Profit | 43.87B | 37.77B | 31.96B | 24.98B | 21.32B |
| Operating Income | 10.00B | 8.19B | 3.76B | 1.06B | 5.16B |
| Net Income | 7.04B | 5.96B | 3.29B | 112.00M | 3.20B |
| EPS | 2.27 | 1.91 | 1.06 | 0.04 | 1.22 |
| EBITDA | 15.44B | 13.91B | 9.09B | 5.11B | 8.08B |
| Gross Margin | 81.12% | 82.45% | 72.06% | 66.76% | 80.09% |
| Operating Margin | 18.50% | 17.88% | 8.47% | 2.82% | 19.39% |
| Net Income Margin | 13.01% | 13.00% | 7.41% | 0.30% | 12.01% |
| R&D Expenses | 13.58B | 10.94B | 9.76B | 9.74B | 5.99B |